Delivery Order SPE2DB22D2006-SPE2DB24FV5ZA
Award Date 11/2/23
Potential Completion Date 11/3/23
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Humira (adalimumab) 40 mg/0.4 mL, a biologic medication used to treat various autoimmune conditions. The contract has a ceiling value of $9,135.02 and an ultimate completion date of May 8, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,622.88 firm fixed-price contract is for the supply of Humira (adalimumab) 40 mg/0.4 mL syringes, a biologic medication used to treat various autoimmune conditions. This contract is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a broad range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Humira (adalimumab) 40 mg/0.4 mL medication. The contract has a firm-fixed price of $1,764.52 and a completion date of September 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Humira (adalimumab) 40 mg/0.4 mL, a medication used to treat various autoimmune conditions. The contract has a ceiling value of $2,166.48 and a period of performance through July 16, 2025. The contract is not set aside for any specific business type....
- This is a $2,265.90 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of HUMIRA(CF) 40 MG/0.4 ML syringes, a specialty medication used to treat various medical conditions. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,823.32, is for the delivery of Humira (adalimumab) 40 mg/0.4 mL, a biologic medication used to treat various autoimmune conditions. The contract is a firm-fixed-price delivery order with a period of performance through May 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $9,855 firm fixed-price contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a biologic medication used to treat various autoimmune conditions. The contract has a completion date of February 2, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of Humira (adalimumab) 40 mg/0.4 mL auto-injector pens, a specialty medication used to treat various autoimmune conditions. The contract has a firm fixed price of $2,770.74 and a period of performance through August 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...
- This is a $53,822.10 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a biologic medication used to treat various autoimmune conditions. The contract has an ultimate completion date of March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
- This is a $16,226.85 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FV5ZADelivery Order
This is a $19,434 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Humira (adalimumab) 40 mg/0.4 mL, a biologic medication used to treat various autoimmune conditions. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through open competition.
Generated 5/12/25, 10:04 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.4k | 11/2/23 |